Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The use of combined remote electronic monitoring and blood concentrations of antipsychotics for assessment of therapeutic adherence in patients with schizophrenia: results of a prospective study

P. Šilhán, M. Hýža, S. Ambroš, P. Dostálek, J. Schwarzová, T. Skřont, D. Perničková, P. Baarová, M. Augustynek, I. Kacířová, R. Uřinovská

. 2025 ; 25 (1) : 523. [pub] 20250522

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25015681

BACKGROUND: Schizophrenia is a serious mental illness, the pharmacological treatment of which comprises primarily the use of antipsychotics. However, non-adherence to their use and its reliable determination present a serious clinical and economic problem. This study aimed to determine therapeutic adherence in outpatients with schizophrenia spectrum disorders by combining short-term electronic monitoring of dispenser opening with the measurement of antipsychotic blood concentrations. METHODS: A total of 55 patients underwent a week-long electronic monitoring of dispenser opening and measurement of blood concentrations before and after monitoring. Patients who correctly opened the dispenser at least in 80% of scheduled time points during the weekly interval and, at the same time, did not show a change in blood concentration of the antipsychotic by more than 30% in any direction, were considered adherent. RESULTS: 69.1% of the patients met the adherence criteria, which was less than that determined by the Drug Attitude Inventory (DAI-10), the Visual Analogue Scale (VAS), and the Clinician Rating Scale (CRS). 7.3% of the patients took less than 80% of the prescribed doses and a change in blood concentrations of the antipsychotic by more than 30% was detected in 25.4% of the patients. In 70.9% of patients, the detected concentrations were within the recommended therapeutic reference interval. The groups of adherent and non-adherent patients did not differ statistically significantly in the severity of their illness as determined by the Clinical Global Impression (CGI), the Personal and Social Performance scale (PSP), and the Positive and Negative Syndrome Scale (PANSS). CONCLUSIONS: The combined method of evaluating adherence in schizophrenia patients confirmed the results determined by other methods. The benefits of this approach are described in the paper.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25015681
003      
CZ-PrNML
005      
20250731091151.0
007      
ta
008      
250708s2025 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12888-025-06981-3 $2 doi
035    __
$a (PubMed)40405111
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Šilhán, Petr $u Department of Psychiatry, University Hospital Ostrava, 17. listopadu 1790, Ostrava, Poruba, 708 52, Czech Republic $u Department of Clinical Neurosciences, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
245    14
$a The use of combined remote electronic monitoring and blood concentrations of antipsychotics for assessment of therapeutic adherence in patients with schizophrenia: results of a prospective study / $c P. Šilhán, M. Hýža, S. Ambroš, P. Dostálek, J. Schwarzová, T. Skřont, D. Perničková, P. Baarová, M. Augustynek, I. Kacířová, R. Uřinovská
520    9_
$a BACKGROUND: Schizophrenia is a serious mental illness, the pharmacological treatment of which comprises primarily the use of antipsychotics. However, non-adherence to their use and its reliable determination present a serious clinical and economic problem. This study aimed to determine therapeutic adherence in outpatients with schizophrenia spectrum disorders by combining short-term electronic monitoring of dispenser opening with the measurement of antipsychotic blood concentrations. METHODS: A total of 55 patients underwent a week-long electronic monitoring of dispenser opening and measurement of blood concentrations before and after monitoring. Patients who correctly opened the dispenser at least in 80% of scheduled time points during the weekly interval and, at the same time, did not show a change in blood concentration of the antipsychotic by more than 30% in any direction, were considered adherent. RESULTS: 69.1% of the patients met the adherence criteria, which was less than that determined by the Drug Attitude Inventory (DAI-10), the Visual Analogue Scale (VAS), and the Clinician Rating Scale (CRS). 7.3% of the patients took less than 80% of the prescribed doses and a change in blood concentrations of the antipsychotic by more than 30% was detected in 25.4% of the patients. In 70.9% of patients, the detected concentrations were within the recommended therapeutic reference interval. The groups of adherent and non-adherent patients did not differ statistically significantly in the severity of their illness as determined by the Clinical Global Impression (CGI), the Personal and Social Performance scale (PSP), and the Positive and Negative Syndrome Scale (PANSS). CONCLUSIONS: The combined method of evaluating adherence in schizophrenia patients confirmed the results determined by other methods. The benefits of this approach are described in the paper.
650    _2
$a lidé $7 D006801
650    12
$a schizofrenie $x farmakoterapie $x krev $7 D012559
650    12
$a antipsychotika $x krev $x terapeutické užití $7 D014150
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a dospělí $7 D000328
650    _2
$a prospektivní studie $7 D011446
650    _2
$a lidé středního věku $7 D008875
650    12
$a monitorování léčiv $x metody $7 D016903
650    12
$a adherence k farmakoterapii $x psychologie $7 D055118
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hýža, Martin $u Department of Psychiatry, University Hospital Ostrava, 17. listopadu 1790, Ostrava, Poruba, 708 52, Czech Republic. martin.hyza@fno.cz $u Department of Clinical Neurosciences, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. martin.hyza@fno.cz
700    1_
$a Ambroš, Samuel $u Department of Psychiatry, University Hospital Ostrava, 17. listopadu 1790, Ostrava, Poruba, 708 52, Czech Republic $u Department of Clinical Neurosciences, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
700    1_
$a Dostálek, Petr $u Department of Psychiatry, University Hospital Ostrava, 17. listopadu 1790, Ostrava, Poruba, 708 52, Czech Republic $u Department of Clinical Neurosciences, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
700    1_
$a Schwarzová, Jana $u Department of Psychiatry, University Hospital Ostrava, 17. listopadu 1790, Ostrava, Poruba, 708 52, Czech Republic $u Department of Clinical Neurosciences, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
700    1_
$a Skřont, Tomáš $u Department of Psychiatry, University Hospital Ostrava, 17. listopadu 1790, Ostrava, Poruba, 708 52, Czech Republic
700    1_
$a Perničková, Denisa $u Department of Psychiatry, University Hospital Ostrava, 17. listopadu 1790, Ostrava, Poruba, 708 52, Czech Republic $u Department of Clinical Neurosciences, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
700    1_
$a Baarová, Pavla $u Department of Clinical Neurosciences, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
700    1_
$a Augustynek, Martin $u Department of Cybernetics and Biomedical Engineering, Faculty of Electrical Engineering and Computer Science, VSB-Technical University Ostrava, Ostrava, Czech Republic
700    1_
$a Kacířová, Ivana $u Department of Clinical Pharmacology, Institute of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czech Republic $u Institute of Clinical Pharmacology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
700    1_
$a Uřinovská, Romana $u Department of Clinical Pharmacology, Institute of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czech Republic $u Institute of Clinical Pharmacology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
773    0_
$w MED00008204 $t BMC psychiatry $x 1471-244X $g Roč. 25, č. 1 (2025), s. 523
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40405111 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250708 $b ABA008
991    __
$a 20250731091146 $b ABA008
999    __
$a ok $b bmc $g 2366500 $s 1252806
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 25 $c 1 $d 523 $e 20250522 $i 1471-244X $m BMC psychiatry $n BMC Psychiatry $x MED00008204
LZP    __
$a Pubmed-20250708

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...